Skip to main content

Day: September 22, 2020

Microchip Introduces No-Cost, License- and Royalty-Free Ensemble Graphics Toolkit to Speed Linux® Graphical User Interface Development

CHANDLER, Ariz., Sept. 22, 2020 (GLOBE NEWSWIRE) — Graphical user interfaces (GUIs) and interactive touchscreen displays provide intuitive user experiences in applications from robotic and machine controls to medical user interfaces, automotive instrumentation and home and building automation systems. A well-designed GUI enables users to process information more quickly and interact more effectively with a product. Microchip Technology Inc. (Nasdaq: MCHP) today announced a new GUI development toolkit for its portfolio of 32-bit microprocessors (MPUs) running Linux, helping designers of industrial, medical, consumer and automotive graphical displays to reduce development cost and time-to-market.Microchip’s new Ensemble Graphics Toolkit is a free and open-source C++ GUI suite for the company’s SAMA5 and SAM9 series of Arm® Cortex®-A5...

Continue reading

Galectin Therapeutics Announces Investor Conference Call and Webinar on September 29, 2020

NORCROSS, Ga., Sept. 22, 2020 (GLOBE NEWSWIRE) — Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, announced today that the Company will host an investor conference call and webinar to discuss the Company’s NASH-RX clinical trial and to introduce its new CEO, Joel Lewis. The Investor Call is scheduled for Tuesday, September 29, 2020, at 4:00 p.m. EDT.The presentation can be accessed by dialing (844) 899-6544 and entering the conference ID: 3695038 or at the following webcast link: https://edge.media-server.com/mmc/p/hmudntyg. A copy of the presentation to be used for the call can be found on the Company’s website at https://investor.galectintherapeutics.com/investor-relations.The call is expected to last one hour, including a Q&A session that will follow the formal...

Continue reading

Correction: Final terms for bond to be opened 23rd September 2020

To Nasdaq Copenhagen A/S                                                               21 st   September 2020                                                                                                             Announcement no. 95/2020Correction: The terms for value at Redemption due to negative interest rate was not set in the previously published final terms. The attached final terms replace previously published ones.The full prospectus for the Bond consist of the attached final terms and the previously disclosed ”Base Prospectus for the issue of Covered Bonds (SDO), Mortgage bonds (“RO”) and Mortgage Bonds (RO) and bonds issued pursuant to Section 15 of the Danish Mortgage-Credit Loans and Mortgage-Credit Bonds etc. Act (Section 15 Bonds).”, dated February 24th, 2020.Jyske Realkredit’s base prospectus is available on Jyske Realkredit’s...

Continue reading

Correction: Endelige vilkår for ny obligation der åbnes den 23. september 2020

Til Nasdaq Copenhagen A/S                                                                                       21. september 2020                                                                                                                                                 Meddelelse nr. 95/2020Rettelse: Vilkåret for kurs ved udtrækning som følge af negativ rente var ikke sat i de tidligere offentliggjorte endelige vilkår. Vedlagte endelige vilkår erstatter tidligere offentliggjorte. Jyske Realkredit åbner den 23. september 2020 ny særligt dækkede obligation (SDO). Med denne meddelelse følger de endelige vilkår for obligationerne.Det samlede prospekt for obligationerne består af vedlagte endelige vilkår og det tidligere offentliggjorte ”Basisprospekt for udstedelse af Særligt Dækkede Obligationer (SDO), Realkreditobligationer (RO) og...

Continue reading

ZDD listed on OTC market in USA

Boca Raton, FL, Sept. 22, 2020 (GLOBE NEWSWIRE) — The assets of Henan Anjia e-commerce Co., Ltd. (Stock Code: zdd) will be loaded into the listed company in the form of reverse merger and acquisition. The company will issue 1 billion shares, and Cui Weiming will be appointed as the chairman and director, and Chang Xu as the director. The company’s “earn more” brand has deeply cultivated the differentiated e-commerce and community e-commerce to seek the welfare of the common people. The company appointed Ouyang Chengguo as the chairman, Wen Qingrui as the vice chairman, Wang Jinhui as the CEO, Ouyang Chengguo, Wen Qingrui, Wang Jinhui, Ma Liying, LV Baoshu, Xu Yulan, Yin Li, Han fengzhe and Liu Huiwu as directors, and Ouyang Jianwen as the Secretary of the board of directors.Zdd acquired OMPs through reverse merger...

Continue reading

OMNIQ Corp. Awarded $1.8-Million Project from a Multi-billion Dollar Global Metal Solutions Provider

Project includes supply of mobile devices, software and services for the implementation of an advanced logistics program for product deliveriesAward follows over $7.5 million in orders from the Healthcare and Logistic Services verticals announced during Q3SALT LAKE CITY, Sept. 22, 2020 (GLOBE NEWSWIRE) — OMNIQ Corp. (OTCQB: OMQS) (“OMNIQ” or “the Company”), a provider of Supply Chain and Artificial Intelligence (AI)-based solutions, today announced that it has been awarded a project with a total value of approximately $1.8 million by a global metal solutions provider and one of the largest metals services companies in North America. The project consists of approximately $1.2 million for the supply of Android-based mobile computing devices with communication capabilities and approximately $0.6 million for software and services. It...

Continue reading

Origin Bank Gains Lending Efficiency and an Improved Customer Experience With nCino

WILMINGTON, N.C., Sept. 22, 2020 (GLOBE NEWSWIRE) — nCino, Inc. (NASDAQ: NCNO), a pioneer in cloud banking and digital transformation solutions for the global financial services industry, today announced that $5.3 billion-asset Origin Bank has implemented the nCino Bank Operating System to create better efficiency in its loan origination process and a more streamlined client experience through enhanced digital engagement capabilities.Headquartered in Choudrant, Louisiana and serving communities throughout Louisiana, Texas and Mississippi, Origin Bank places a strong focus on client service. Origin recognized that in a competitive banking landscape with numerous options for clients to choose from, it needed a strong digital presence to meet existing and future clients’ needs and expectations. By implementing nCino’s Commercial Banking...

Continue reading

Healthcare Valuation Expert Todd Mello Joins FTI Consulting as a Senior Managing Director

WASHINGTON, Sept. 22, 2020 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced continued investment in its healthcare valuation capabilities with the appointment of Todd Mello as a Senior Managing Director and Leader of the Valuation Services group within the firm’s Health Solutions practice.Based in Brentwood, Tenn., Mr. Mello brings 30 years of valuation and transactions experience, 10 of which were spent in the managed care, physician practice management and investment banking fields.“Valuation is a complex process that requires a skillful blend of analysis, industry experience and well-founded judgment,” said Tim Renjilian, a Senior Managing Director in the Health Solutions practice at FTI Consulting. “Our Valuation Services team has assisted some of the largest healthcare systems, pharmaceutical companies and...

Continue reading

Auxly’s Subsidiary KGK Science Receives Research Licence to Conduct Product Palatability and Sensory Testing with Human Subjects

TORONTO, Sept. 22, 2020 (GLOBE NEWSWIRE) — Auxly Cannabis Group Inc. (TSX.V – XLY) (“Auxly” or the “Company”), a consumer packaged goods company in the cannabis products market, is thrilled to announce that its wholly owned subsidiary, KGK Science Inc. (“KGK”) has received its second Cannabis Research Licence from Health Canada pursuant to the Cannabis Act. This licence permits KGK to administer cannabis extracts, edible cannabis and cannabis topicals to human subjects for purposes of palatability and sensory testing at its clinical research facility located in London, Ontario.Sensory evaluation measures, analyzes and interprets the reaction of human subjects to products as perceived by the senses, it is an incredibly valuable tool in understanding and determining consumer preferences and the basis for those differences....

Continue reading

Genocea Announces FDA Acceptance of GEN-011 IND Application

CAMBRIDGE, Mass., Sept. 22, 2020 (GLOBE NEWSWIRE) — Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, today announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s Investigational New Drug (IND) Application for GEN-011, an adoptive T cell therapy targeting neoantigens and designed to improve upon the limitations of TIL and TCR therapies. The IND allows Genocea to initiate a Phase 1/2a clinical study of GEN-011 in patients who have failed standard-of-care checkpoint inhibitor therapy. The trial will evaluate safety, T cell proliferation and persistence as well as clinical activity.“GEN-011 builds on the power of our ATLAS™ platform, as demonstrated in our GEN-009 clinical trial, to identify the relevant neoantigens which drive...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.